Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 13, 2021

View Archived Issues

GeneTACs show promise for treating myotonic dystrophy type 1

Jiangsu Simcere Pharmaceutical R&D patents DNA repair protein RAD51 homolog 1 inhibitors

Sphingomyelin-derived camptothecin nanovesicle platform for improved cancer immunochemotherapy

Unveiling immune-malignant cell hubs underlying cancer immunologic and tumorigenic processes

Engineered macrophages for chemo/photo/immunotherapy of primary and bone metastatic breast cancer

JMJD1C demethylase as novel target for AR-negative prostate cancer

Inflazome patents NLRP3 inflammasome inhibitors

Janssen Pharmaceutica presents Mcl-1 inhibitors

Shanghai Henlius Biotech discloses CD137-targeting antibodies

MASP2 levels are increased in children with severe asthma

Metabolomics study reveals dementia-linked metabolites

PRS-220 shows favorable PK and biodistribution in fibrotic lung models

KIM-1 unveiled as a marker of COVID-19 severity

Combined inhibition of RIPK1 and ferroptosis as potential therapeutic strategy for AKI

ARN-19702 shows broad analgesic effect in animal models of pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...